To determine whether improved T-cell responses were related to changes in the apoptotic signalling balance between BCL2 and BAX, real-time PCR was used to measure BCL2 and BAX expression in cells from HC, active RA and CR patients. This evidence concerns the gene BCL2 and rheumatoid arthritis.